Install
- 533articles · 30d
- 11+ hour agolatest article
- Aug 15, 2026earliest in window
- 92%with images
- 358avg words
- business 381
- stocks 341
- finance 308
- investing 267
- markets 257
- stock 247
- canada 185
- mortgages 183
- real estate 180
- tfsa 175
- rrsp 172
- etfs 170
- gic rates 166
- technology 164
- financial calculators 160
- canadian finance 157
- finance & insurance 133
- stock market 132
- artificial intelligence 118
- all news and stock ideas 101
- Economy, Business & Finance 533
- Finance & Business 528
- News 340
- Finance 149
- Business & Industrial 20
- Autos & Vehicles 7
- Travel & Transportation 6
- Health & Wellness 5
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Roivant Sciences Stock Rallies 20% On Positive Phase 2 Trial Results For Pulmovant Drug
5+ day, 3+ hour ago (497+ words) @SUWANNAR KAWILA via Canva, @Artsanova from Getty Images via Canva Roivant Sciences (ROIV) stock jumped 22% in premarket trading after some genuinely exciting drug trial news. By the end of the day, the stock was up 19%. The company’s Pulmovant subsidiary shared…...
Roivant Sciences Stock Slides Despite FDA Approval of Dermatomyositis Drug LISRAYA
1+ week, 6+ day ago (459+ words) @SHVETS production from Pexels via Canva, @Ivan S from Pexels via Canva Roivant Sciences (ROIV) stock fell 8% on Friday, even after the FDA approved LISRAYA, the first oral treatment for adults with dermatomyositis. The drop wiped out roughly $720 million in…...
Moderna Stock Skyrockets 177% After Positive Late-Stage Skin Cancer Vaccine Trial Results
3+ week, 3+ day ago (503+ words) 💥Build Your Research Hub Your Way.New users are invited to save 20% for a limited time @vladeep via Canva, @Sezeryadigar from Getty Images Signature via Canva Moderna (MRNA) stock exploded higher on Wednesday, jumping about 177% after Moderna and Merck announced…...
Merck Stock Gains 13% As Experimental Melanoma Vaccine Trial With Moderna Meets Key Goals
3+ week, 3+ day ago (506+ words) 💥Build Your Research Hub Your Way.New users are invited to save 20% for a limited time @vladeep via Canva, @MariaBrzostowska from Getty Images via Canva Merck (MRK) stock climbed more than 12% on Wednesday after Merck and Moderna announced strong results…...